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(57)	 ABSTRACT
The present invention provides methods and apparatus for
determining a dynamical property of the systemic or pulmo-
nary arterial tree using long time scale information, i.e., infor-
mation obtained from measurements over time scales greater
than a single cardiac cycle. In one aspect, the invention pro-
vides a method and apparatus for monitoring cardiac output
(CO) from a single blood pressure signal measurement
obtained at any site in the systemic or pulmonary arterial tree
or from any related measurement including, for example,
fingertip photoplethysmography.
According to the method the time constant of the arterial tree,
defined to be the product of the total peripheral resistance
(TPR) and the nearly constant arterial compliance, is deter-
mined by analyzing the long time scale variations (greater
than a single cardiac cycle) in any of these blood pressure
signals. Then, according to Ohm's law, a value proportional
to CO may be determined from the ratio of the blood pressure
signal to the estimated time constant. The proportional CO
values derived from this method may be calibrated to absolute
CO, if desired, with a single, absolute measure of CO (e.g.,
thermodilution). The present invention may be applied to
invasive radial arterial blood pressure or pulmonary arterial
blood pressure signals which are routinely measured in inten-
sive care units and surgical suites or to noninvasively mea-
sured peripheral arterial blood pressure signals or related
noninvasively measured signals in order to facilitate the clini-
cal monitoring of CO as well as TPR.
14 Claims, 10 Drawing Sheets
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METHODS AND APPARATUS FOR	 arterial tree in FIG. 1A results. Most of these types of pulse
DETERMINING CARDIAC OUTPUT
	
	
contour methods are specifically based on mathematical for-
mulas which are derived by making simplifying assumptions
CROSS-REFERENCE TO RELATED	 and approximations to this model (see, for example, [7,
APPLICATION
	
	
5 19-21, 26, 40, 43, 44]). These methods have generally failed
to yield good correlation between CO determined from analy-
This application claims priority to U.S. Provisional Patent 	 sis of ABP signals and directly measured CO over a wide
Application 60/446,385, filed Feb. 10, 2003, which is hereby 	 range of physiologic conditions [39, 42].
incorporated by reference.	 Bourgeois et al. [3,4] did successfully demonstrate that
io their pulse contour method when applied to an ABP signal
GOVERNMENT SUPPORT 	 measured centrally in the aorta could yield a quantity which
varied linearly with directly measured CO (electromagnetic
This invention was made with government support under	 aortic flow probe) over a wide range of physiologic condi-
Contract Number NAGS-4989, awarded by the National 	 tions. Their method, which makes no simplifying assump-
Aeronautics and Space Administration (NASA). The govern- 15 tions or approximations to the model of FIG. 1A, may be
ment has certain rights in this invention. 	 explained as follows. During the diastolic period of each
cardiac cycle, the heart is filling and not supplying blood to
BACKGROUND OF THE INVENTION	 the arterial tree (see FIG. 113). Thus, according to the model,
ABP decays with a time constant TD equal to the product of
Cardiac output (CO) is defined to be the volume of blood 20 TPR andAC during each diastolic period (see FIG. 113). Since
ejected by the heart per a unit time. Since CO also represents 	 AC is essentially constant over a wide pressure range and on
the total flow of blood supplying all the tissue beds of the 	 the time scale of days [4, 18,37], CO could then be monitored
body, it is perhaps the most indicative quantity of the state of 	 to within a constant scale factor (equal to the reciprocal of
the heart and circulation. CO is routinely measured in inten- 	 AC) by dividing the ABP by time.
sive care units and surgical suites in order to monitor and 25	 Bourgeois et al. specifically demonstrated that beat-to-beat
guide therapy for critically ill patients. These patients include, 	 CO may be monitored from TD and the governing differential
for example, those in shock (e.g., cardiogenic, hemorrhagic,	 equation of the model of FIG. IA. Thus, a key step of the pulse
or septic) or heart failure and those during and after surgery 	 contour method of Bourgeois et al. is to fit an exponential to
(e.g., coronary artery bypass grafting or heart valve replace- 	 the diastolic decay portion of an ABP wavelet in order to
ment.)	 30 measure time . Osborn et al. [34] introduced essentially the
An ideal CO measurement technique would be simple to 	 same method prior to Bourgeois et al. but their experimental
perform, inexpensive, noninvasive or minimally invasive and 	 validation was not as complete or compelling.
safe, and very accurate. However, none of the conventional 	 Bourgeois et al. were able to validate their pulse contour
measurement techniques known in the art possess all of these 	 method with respect to a canine ABP signal measured cen-
characteristics [10]. For example, the thermodilution tech-  35 trally in the aorta, because the diastolic portion of such a
nique, which is currently employed in most intensive care	 signal usually resembles an exponential decay (see FIG. 2A).
units and surgical suites, involves injecting cold saline into	 These investigators specifically identified the position in the
the right atrium and measuring the temperature downstream	 aorta at the level of the dorsal insertion of the diaphragm as
in the pulmonary artery. The average CO over the measure- 	 the optimal site for observing an exponential diastolic decay.
ment period may than be computed from conservation of 4o However, Bourgeois et al. acknowledged that central ABP is
mass laws. Although the technique is relatively simple and 	 rarely obtained clinically because of the difficulty in inserting
inexpensive, it requires an invasive right heart catheterization 	 a catheter retrogradely via a peripheral arterial blood vessel
whose safety is questionable [8,38] and is not very accurate	 and the risk of blood clot formation and embolization. More-
due to the many assumptions upon which it is based (e.g., no 	 over, they recognized that, in peripheral ABP signals which
saline recirculation and thorough blood mixing) [10,27] . The 45 are routinely made available in intensive care units and sur-
most accurate, conventional technique for measuring CO	 gical suites usually via a more simple and safe radial artery
involves surgically implanting a flow probe, either electro-	 catheterization, an exponential diastolic decay is usually not
magnetic or ultrasonic, directly on the aorta. Although this 	 apparent (see FIG. 213). The method of Bourgeois et al. there-
technique also provides a continuous measurement of CO, it 	 fore cannot generally be applied to readily available periph-
requires a high risk thoracotomy which is rarely performed in 50 eral ABP signals. In fact, its application to central ABP sig-
practice. Moreover, the accuracy of the aortic flow probe is	 nals may be somewhat limited, as Cundick et al. [9] reported
highly dependent on vessel preparation and may only be 	 that they could not identify an optimal location in the human
accurate to within about 15-20 percent [10,27]. 	 aorta in which the diastolic portion of the ABP signal
Although the development of an ideal CO measurement 	 appeared as a pure exponential decay.
technique has proven to be difficult, several ideal, or near 55	 Other pulse contour methods that are based on more com-
ideal, techniques are currently available for the continuous 	 plex representations of the arterial tree have also been devel-
measurement of peripheral arterial blood pressure such as	 oped (see, for example, [5, 11, 12, 16, 24, 31-33, 50]). How-
Finapres technology [23] and arterial tonometry [25]. Previ- 	 ever, these techniques required the analysis of one, or even
ous investigators have therefore sought techniques to monitor 	 two, central ABP signals. Thus, their clinical utility is also
CO from peripheral arterial blood pressure signals. The most 60 severely limited.
popular techniques in the art are the so-called pulse contour	 Several techniques have more recently been introduced in
methods that assume the arterial tree to be well represented by 	 an attempt to monitor CO fromABP signals measuredperiph-
a parallel combination of a capacitor and resistor thereby 	 erally. Techniques based on an adaptive aorta model which
accounting for the compliance of the large arteries (AC) and 	 require ABP signals measured at two peripheral sites the
the total peripheral resistance (TPR) of the small arteries. If 65 carotid artery and the femoral artery have been developed
the instantaneous CO supplied by the heart is represented as 	 [36, 46]. However, catheters are usually not placed for pro-
a current source, then the simple model of the heart and
	
longed periods of time at either of these sites in intensive care
US 7,815,578 B2
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units or surgical suites due to issues of safety. Another previ-
ous technique is based on an empirically-derived formula
which involves the calculation of the derivative of the ABP
signal [14]. However, in order to mitigate the corruptive
effects of wave reflections on the derivative calculation, this
technique also requires two peripheral ABP measurements,
one of which is obtained from the femoral artery. Other tech-
niques based on a learning approach have been previously
proposed [6, 15, 30]. However, these techniques require
extremely large sets of training data consisting of simulta-
neous measurements of CO and ABP signals obtained over
the entire range of physiologic conditions. Moreover, the
success of these techniques was only demonstrated with cen-
tral ABP signals or only over a narrow physiologic range.
Finally, Wesseling et al. [1, 48,49] and Linton and Linton [28]
have recently proposed model-based techniques which
require only the analysis of a single radial artery pressure
signal. However, Linton and Linton showed that their tech-
nique was reasonably accurate only over a narrow range of
physiologic conditions, and several previous studies have
demonstrated the inadequacy of the method of Wesseling et
al. (see, for example, [13, 22]).
It is evident that there remains a need in the art for methods
and apparatus for determining CO reliably and accurately
using information obtained from the arterial blood pressure
signal. In particular, there remains a need in the art for meth-
ods and apparatus for determining CO reliably and accurately
using information obtained from the peripheral arterial blood
pressure signal.
SUMMARY OF THE INVENTION
The present invention addresses this need, among others.
In one aspect, the invention provides for the measuring of a
physiologic signal indicative of cardiovascular system activ-
ity, e.g., an arterial blood pressure (ABP) signal over a plu-
rality of cardiac cycles. From analysis of the arterial blood
pressure signal or other physiological signal the times of the
cardiac contractions are identified. Then the relationship
between the times of the cardiac contractions and the physi-
ologic signal over a plurality of cardiac cycles is mathemati-
cally analyzed. From this analysis a mathematical relation-
ship between the occurrence of the cardiac contraction at a
certain time and the subsequent time evolution of the arterial
blood pressure over a time period greater than one cardiac
cycle is obtained. This mathematical relationship is then used
to determine a dynamical property of the system. For
example, in one preferred embodiment the mathematical rela-
tionship is the impulse response function between the occur-
rence of cardiac contractions and the arterial blood pressure
signal. In one preferred embodiment the dynamical property
is the time constant which describes the decay of the impulse
response function over a time interval, e.g., a time interval
such as between 2 and 4 seconds following the maximum
height of the exponential. In another preferred embodiment
the dynamical property is the impulse response function
itself.
In particular, in a preferred embodiment the invention pro-
vides a method and apparatus for monitoring CO by analyz-
ing the long time scale variations (greater than a cardiac
cycle) in a single ABP signal, which may be obtained at any
site in the systemic or pulmonary arterial tree. The present
invention determines TD through the analysis of long time
intervals (60-90 second intervals in a preferred embodiment)
of an ABP signal according to the following three steps (see
FIG. 3). The first step involves constructing an impulse train
signal, x(t), in which each impulse is located at the start of a
cardiac contraction and has an area equal to the ensuing
arterial pulse pressure (or an arbitrary constant value in
another preferred embodiment). The constructed signal
therefore approximately reflects cardiac contractions in terms
5 of timing and output (or just timing, in those embodiments in
which the area of the impulses is an arbitrary constant).
The second step deals with determining the dynamical
properties of the arterial tree through the characterization of
the relationship between the cardiac contractions and the
10 ABP signal. This is achieved by estimating an impulse
response function (h(t)) which when convolved with x(t) best
fits the ABP signal (y(t)), according to any of a number of
criteria. The estimated h(t) represents a normalized ABP
response to a single cardiac contraction. The final step
15 involves fitting an exponential to the tail end of the diastolic
decay portion of the estimated h(t) in which the faster wave
reflections have vanished in order to determine time . Accurate
determination of TD is achieved by virtue of h(t) coupling the
long time scale variations in x(t) to y(t).
20 The present invention, which in a preferred embodiment
includes an analog-to-digital converter, a buffer system, a
signal processing unit, and a display and alarm system (see
FIG. 4), may thus be utilized to monitor CO and/or TPR, to
within constant scale factors from any measured ABP signal
25 despite the presence of wave reflections. Note that absolute
CO and/or TPR of the systemic or pulmonary arterial tree
(depending on the signal measurement site) may also be
determined, if desired, by calibration with a single, absolute
measure of CO such as a thermodilution measurement.
30 The present invention may be employed in intensive care
units and surgical suites in which invasive radial ABP signals
are routinely available and pulmonary ABP signals are some-
times available. The present invention may also be applied to
noninvasively measured peripheral ABP signals (e.g.,
35 Finapres technology, arterial tonometry) or noninvasively
measured signals related to ABP (e.g., fingertip photoplethys-
mography [45], ear densitography [17]). Thus, the present
invention could easily be employed in primary care settings,
emergency rooms, and regular hospital beds in order to facili-
40 tate the evaluation of the patient's heart and circulatory state.
This application refers to various patents and publications.
The contents of all of these are incorporated by reference.
BRIEF DESCRIPTION OF THE DRAWING
45
FIG. lA is a simple, lumped model of the heart and arterial
tree (either systemic or pulmonary). CO is cardiac output;
ABP, arterial blood pressure; TPR, total peripheral resistance;
50 
and AC, arterial compliance.
FIG. 1B is a plot of a realistic, continuous CO signal and a
plot of the ABP signal response to the CO signal determined
according to the simple model of FIG. 1A. The time constant
TD governs the dynamical behavior of the simple model.
55	 FIG. 2A is an example of a central ABP signal measured in
an experimental sheep preparation.
FIG. 2B is an example of a peripheral ABP signal measured
in the brachial artery of an experimental dog preparation.
FIG. 3 is an illustration of how one embodiment of the
60 present invention determines TD from a peripheral ABP sig-
nal. PP is arterial pulse pressure; R, the time of the R-wave in
a surface electrocardiogram; x(t), an impulse train signal
representing cardiac contractions; y(t), an ABP signal; and
h(t), the impulse response which when convolved with x(t)
65 best fits y(t).
FIG. 4 is a block diagram of one embodiment of the present
invention.
US 7,815,578 B2
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FIG. 5 is the result of a pilot experimental rabbit study 	 reflections corrupt peripheral ABP signals, but only on rela-
which demonstrates the correspondence between relative CO	 tively short time scales which, however, may exceed the dura-
changes determined from a femoral ABP signal according to 	 tion of a single cardiac cycle, leaving the signal on longer time
the present invention and an aortic flow probe. CO was altered	 scales relatively undisturbed. This implies that the lumped
by various interventions (e.g., pacing, inferior vena cava bal- 5 model in FIG. lA is a valid representation of the long time
loon occlusion, and nitroglycerine). The solid line is the line	 scale dynamics of the arterial tree (either systemic or pulmo-
of identity, and the dashed line is the line that best fits the data	 nary) despite its limitations as an accurate representation of
points.	 the arterial tree over single cardiac cycles. Moreover, the
FIG. 6 shows example excerpts of measured (a) central, (b) 	 arterial tree is continuously being excited at time scales
"radial", and (c) femoral arterial blood pressure (ABP) sig-  io greater than a cardiac cycle by ongoing perturbations (e.g.,
nals from an experiment performed in swine. 	 breathing) and the dynamic, compensatory response of the
FIG. 7 presents results from animal 1 in an experiment in 	 regulatory system (e.g., arterial baroreflex) [2]. Thus signifi-
which the method of the invention was tested in swine. The 	 cant long time scale information is generally present in ABP
top panel illustrates the aortic flow probe cardiac output (CO) 	 signals, and the present invention utilizes this information to
trend (solid), estimated and calibrated CO trends from the 15 provide methods for determining dynamical properties of the
"radial" (dash) and femoral (dash-dot) arterial blood pressure 	 systemic or pulmonary arterial tree.
(ABP) signals, and the intervention and duration (underline). 	 The invention provides a method for determining a
The second panel depicts TD
 
trends estimated from the	 dynamical property of the systemic or arterial tree comprising
"radial" (dash) and femoral (dash-dot) ABP signals. The bot- 	 steps of. (a) measuring a physiologic signal over a plurality of
tom two panels illustrate the mean ABP (MAP) and heart rate 20 cardiac cycles; (b) obtaining a relationship between the tim-
(HR) trends.	 ing of a cardiac contraction and the evolution of the physi-
FIG. 8 present results from animal 5 in an experiment in 	 ologic signal over a time period greater than that of a single
which the method and apparatus of the invention were tested	 cardiac contraction cycle by analyzing the physiologic signal
in swine. Panels correspond to those in FIG. 7.
	
	 over a plurality of cardiac cycles; and (c) using the relation-
25 ship to determine the dynamical property. In general, the
	
DETAILED DESCRIPTION OF CERTAIN	 physiologic signal is a signal indicative of cardiovascular
	
PREFERRED EMBODIMENTS OF THE 	 system activity. For example, in certain embodiments of the
INVENTION	 invention the physiologic signal is an arterial blood pressure
(ABP) signal. In certain embodiments of the invention the
The present invention encompasses the recognition that 30 physiologic signal is a signal related to the ABP signal. Such
there is significant information present in the ABP signal 	 related signals include, but are not limited to, pressure signals
when measured over long time scales (greater than a single 	 obtained using fingertip photoplethysmography [45], ear
cardiac cycle), and that this information, referred to herein as 	 densitography [17], etc. In certain embodiments of the inven-
"long time scale information", may be used to facilitate deter- 	 tion the physiologic signal is the arterial-systemic fillingpres-
mination of dynamical properties of the systemic or pulmo-  s5 sure difference (ASFPD). For purposes of description, the
nary arterial tree. 	 invention will be described in terms of the ABP signal, but it
Long time scale information incorporates information	 is to be understood that other physiologic signals may be
reflecting the variability of the ABP signal between beats in 	 similarly used.
addition to, or instead of, reflecting only information about 	 In general, a dynamical property of a system is a charac-
the ABP signal within single beats. Although long time scale 40 teristic of the system that relates to how the system responds
information is acquired by measuring the ABP signal over a	 over time to a change in one or more of the parameters of the
period greater than a single cardiac cycle (typically seconds to 	 system. For example, a mathematical expression that relates
minutes), not all quantities derived from measurements per- 	 future values of one or more signals generated by a system to
formed over time periods greater than a single cardiac cycle 	 past and present values of signals either sensed or generated
include long time scale information. For example, it is com- 45 by the system would constitute a dynamical property of the
mon to measure ABP over a plurality of cardiac cycles and	 system. A characteristic time is also a dynamical property. In
average the measured amplitudes to obtain mean (average) 	 general, a characteristic time indicates the time scale of the
ABP. However, mean ABP does not incorporate long time 	 temporal evolution of a function. (For example, for an expo-
scale information, because it contains no information reflect- 	 nential function given by y(t)— "', the time constant ti is a
ing the variability between beats. Once an average value is 50 characteristic time of the function.)
found (e.g., by integrating the ABP signal over a time interval 	 In particular an impulse response function which enables
and dividing by the length of the time interval), information 	 one to compute the expected future values of a signal gener-
reflecting differences in length and/or amplitude of the ABP 	 ated by the system from past values of that signal or past
signal is lost. Thus the mean ABP does not incorporate long	 values of other signals either generated or sensed by the
time scale information. 	 55 system would constitute a dynamical property of the system.
Capturing the information present over long time scales	 The characteristic time of the decay of that impulse response
offers a number of advantages for the determination of	 function would also be a dynamical property of the system.
dynamical properties of the systemic or pulmonary arterial 	 Note that the dynamical property need not fully predict how
tree. In particular, utilizing such information provides a 	 the system responds over time to a change in one or more of
means of accurately determining such properties through 60 the parameters of the system, rather it need only be descrip-
measurement of the ABP signal, despite the fact that theABP	 tive of the response. Dynamical properties of systems can
signal (particularly the peripheral ABP signal) is corrupted by 	 often be estimated from analysis of signals associated with
wave reflections that occur at sites of impedance mismatch	 the system.
(e.g., vessel bifurcations).	 The relationship between the timing of a cardiac contrac-
The inventors have recognized that at sufficiently longtime 65 tion and the evolution of the ABP signal over time may be
scales, the wavelengths of the propagating waves may be	 obtained in a number of different ways. Determination of one
longer than the dimension of the arterial tree. Thus the wave 	 or more dynamical properties of the systemic or pulmonary
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arterial tree in turn allows one to obtain values for a variety of
important parameters that characterize the cardiovascular
system, including, but not limited to, cardiac output, total
peripheral resistance, cardiac index, stroke volume, charac-
teristic time constant, etc.
One application of the methods described above is in mea-
suring cardiac output (CO). The invention provides a method
of determining cardiac output to within a constant scale factor
comprising steps of: (a) measuring a physiologic signal over
a plurality of cardiac contraction cycles; (b) estimating a
function that represents the response of the physiologic signal
to a cardiac contraction over a time period greater than that of
a single cardiac cycle; (c) determining a characteristic time of
the function; (d) determining cardiac output to within a con-
stant scale factor by dividing the magnitude of the physi-
ologic signal by the characteristic time obtained in step (c).
The invention further provides a method of determining total
peripheral resistance to within a constant scale factor com-
prising steps of: (a) measuring a physiologic signal over a
plurality of cardiac contraction cycles; (b) estimating a func-
tion that represents the response of the physiologic signal to a
cardiac contraction over a time period greater than that of a
single cardiac cycle; and (c) determining a characteristic time
of the function, wherein total peripheral resistance is given to
within a constant factor by the characteristic time.
In certain embodiments of the invention rather than deter-
mining the characteristic time of the function estimated in
part (b) of the above methods, a second function that repre-
sents the response of a different physiologic signal to a car-
diac contraction over a time period greater than that of a single
cardiac contraction is estimated, and the characteristic time of
this second function is determined and used in step (d).
Accordingly, the invention provides a method of determining
cardiac output to within a constant scale factor comprising
steps of: (a) measuring a first physiologic signal over a plu-
rality of cardiac contraction cycles; (b) measuring a second
physiologic signal over a plurality of cardiac contraction
cycles; (c) estimating a function that represents the response
of the second physiologic signal to a cardiac contraction over
a time period greater than that of a single cardiac cycle; (d)
determining a characteristic time of the function; and (e)
determining cardiac output to within a constant scale factor
by dividing the magnitude of the first physiologic signal by
the characteristic time obtained in step (d). The methods will
now be described in more detail.
A feature common to the techniques discussed above for
monitoring CO from continuous ABP is that the signal analy-
sis is considered only within individual cardiac cycles.
Because of the presence of wave reflections at these time
scales, these techniques are limited in that they 1) can only be
applied to central ABP signal in which the cumulative effects
of the pulse reflections are largely attenuated; 2) necessitate
two peripheral ABP signal measurements which are not usu-
ally obtained clinically; 3) require a large set of training data
obtained over a wide range of physiologic conditions, or 4)
are reasonably accurate only over a limited physiologic
range.
In particular, methods that attempt to determine CO by
measuring the time constant (TD) of the arterial tree, which
could then be used to compute CO to within a constant scale
factor (equal to the reciprocal of AC) have had only limited
success for the following reasons. In peripheral ABP signals
such as those typically available in intensive care units and
surgical suites via a technique such as radial artery catheter-
ization (and also peripheral ABP signals obtained via non-
invasive techniques such as fingertip photoplethysmography
or ear densitography), an exponential decay is not usually
8
apparent (see FIG. 213). This is because, as mentioned above,
the arterial tree is not a lumped system but actually a distrib-
uted system with impedance mismatches throughout the sys-
tem due to vessel tapering and bifurcations as well as changes
5 in vessel caliber. Thus the diastolic portion (as well as the
systolic portion) of peripheral ABP signals is corrupted by
wave reflections that occur at each site of impedance mis-
match. (Note that the complexity of these sites as well as their
varying distances from the aorta result in reflected waves with
io large phasic differences which generally tend to mitigate the
cumulative effects of these waves on the central ABP signal.)
Even in the case of central APB signals it may not be possible
to identify an optimal location in the human aorta at which the
diastolic portion of the ABP signal appears as a pure expo-
15 nential decay [9]. Similarly, efforts to locate a suitable posi-
tion in the pulmonary arterial tree in which the diastolic
portions of the pulmonary ABP signal appear as an exponen-
tial decay have been unsuccessful [41].
Thus the presence of wave reflections has impeded devel-
20 opment of accurate methods to determine the time constant of
the arterial tree, which could then be employed to compute
CO. As describedbelow, the present invention overcomes this
difficulty through the use of long time scale information to
accurately estimate TD, from which CO may then be deter-
25 mined using the following formula:
CO= (ABP)(AC)
TD
30
The scale factor, AC, for a particular individual may be
determined by obtaining a single absolute measurement of
CO, e.g., by thermodilution, and then solving for AC in the
35 above formula using the estimated value for TD. Alternately,
AC may be estimated using tables or nomograms, which are
well known in the art and may be based on parameters such as
age, weight, height, orparticular disease status (see, e.g., U.S.
Pat. No. 6,485,431). Additional parameters such as total
40 peripheral resistance (TPR), cardiac index, stroke volume
(SV), etc., may also be determined using well known rela-
tionships. For example, TPR=(TD)/AC, TPR=ABP/CO, and
SV=(CO)/heart rate.
The CO signal estimated from the formula given above will
45 reflect true CO over time periods greater than or equal to a
single cardiac cycle, but will generately not accurately reflect
the cardiac flow signal within a single cardiac cycle. For this
reason, it may be desirable to average the ABP signal or the
estimated CO signal over each cardiac cycle. Alternatively, in
50 certain embodiments of the invention the ABP signal or esti-
mated CO signal is filtered using a low-pass filter with a
characteristic response time greater than the duration of a
typical cardiac cycle. Another alternative is to simply average
the ABP signal or estimated CO signal over a time period
55 longer than the duration of a typical cardiac cycle (multibeat
averaging). In general, a single-beat average approach or by
use of a low-pass filter with a fairly short characteristic time
would be expected to retain the most information regarding
time variation of the CO signal as compared with simple
6o averaging of the CO signal over long time periods. The time
constant TD changes slowly in time (because over a time scale
of tens of seconds peripheral resistance is slowly varying and
the arterial compliance AC may be regarded as essentially
constant), however the cardiac output itself can vary much
65 more rapidly—on a beat-to-beat basis. Thus it is generally
preferable to estimate the CO from the formula given above
together with use of a single beat average or low-pass filtering
US 7,815,578 B2
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approaches even if the constant TD
 
is estimated from long
epochs of data comprising perhaps tens of seconds as
opposed to simple averaging over time scales long compared
to the duration of a single cardiac cycle.
Although absolute CO may be determined using the for-
mula given above, one important aspect of the invention is the
recognition that in many circumstances it is not necessary to
obtain a value for absolute CO. For example, in the context of
continuous monitoring in the acute setting (e.g., in intensive
care units), it is changes in CO rather than absolute CO that is
most clinically relevant. Thus determination of the propor-
tionality constant is unnecessary, and this potential source of
error may thus be avoided. In other words, the present inven-
tion may be used to monitor CO (e.g., identify and quantify
changes in CO) instead of (or in addition to) determining
absolute CO.
According to the method of the invention an analog ABP
signal is measured invasively or noninvasively at any site in
the systemic or pulmonary arterial tree. The analog signal is
quantized and sampled. For example, in a preferred embodi-
ment of the method the signal is quantized at 12 bits and
sampled at 90 Hz. It is noted that these values are exemplary
only, and one of ordinary skill in the art will readily be able to
select other appropriate values. A signal representing cardiac
contractions is constructed through the formation of an
impulse train in which each impulse is located at the start of
a cardiac contraction and has an area equal to the ensuing
arterial pulse pressure, i.e., the pulse pressure that results
from that cardiac contraction (see FIG. 3). The start of each
cardiac contraction is determined by detecting the onset of the
upstroke of each ABP wavelet, which may be done by any of
a variety of methods known in the art, e.g., those described in
[51], [52], or [53]. The arterial pulse pressure for each wavelet
is given by the difference in the maximum value of ABP and
the value of ABP at the onset of the upstroke.
Alternatively, the area of each impulse may be set to an
arbitrary constant value. In another preferred embodiment, a
surface electrocardiogram (ECG) is measured simulta-
neously with theABP signal. The two signals are quantized at
12 bits and sampled at 360 Hz. It is noted that these values are
exemplary only, and one of ordinary skill in the art will
readily be able to select other appropriate values. The start of
each cardiac contraction may then be established by detecting
each R-wave of the ECG. In certain embodiments of the
invention the constructed impulse train and ABP signal are
then decimated, e.g., for purposes of noise reduction. For
example, in one embodiment of the invention the constructed
impulse train and ABP signal are decimated from 360 Hz to
90 Hz.
The single contraction ABP response (normalized by
approximately the average arterial pulse pressure when each
impulse is scaled to the ensuing arterial pulse pressure),
which quantitatively characterizes the dynamical properties
of the arterial tree, is determined by estimating the discrete-
time impulse response function (h(t)) which when convolved
with the 90 Hz impulse train (x(t)) "best' fits the 90 Hz ABP
signal (y(t)) in the least squares sense (see FIG. 3).
The impulse response function is assumed to be well rep-
resented by an autoregressive moving average (ARMA)
model which is given below:
y(t) =Y' aiy(t-i) +Y' b;x(t-i)+e(t),
1_	 1_
where e(t) is the residual error term, m and n limit the number
of terms in the model (model order), and the set of parameters
k, b,} completely defines h(t) [29]. Because the ARMA
model is parametric, causality may be imposed, which is
5 necessary for reliably estimating h(t) as x(t) and y(t) are
related in a closed-loop fashion (i.e., y(t) also influences x(t)
through the autonomically mediated heart rate baroreflex)
[47].
For a fixed model order, the set of parameters is estimated
io from 60-90 second intervals of x(t) and y(t) through the
least-squares minimization of the residual error term, which
has an analytic solution [29]. The model order is determined
by an ARMA parameter reduction algorithm that penalizes
for the degree of model complexity [35]. Prior to estimation
15 of h(t), x(t) and y(t) may be lowpass filtered in order to
amplify the contribution of long time scale energy such that
the least squares fit between x(t) and y(t), at these time scales,
is prioritized. Note that any other parametric model (e.g.,
autoregressive moving average with exogenous input (AR-
20 MAX) model [29]) may be employed in various embodi-
ments of the invention to represent the structure of h(t), and
any other minimization criterion (e.g., absolute error) may be
utilized to find the "best' h(t). In certain embodiments of the
invention the number of parameters in the model is selected at
25 least in part based on the heart rate.
The TD quantity is determined by finding the "best' expo-
nential that fits h(t) over a selected time interval following the
time of the maximum value of h(t), preferably a time interval
in which the faster wave reflections have become minimal.
3o For example, as shown in the plot of h(t) presented in FIG. 3,
the contribution of the faster wave reflections becomes mini-
mal at approximately 1.5-2 seconds, as evidenced by the
decrease in fluctuations of h(t). Following this time the
impulse response may be accurately approximated as an
35 exponential. Thus in certain preferred embodiments of the
invention the selected time interval begins approximately 1.5
seconds following the time of maximum h(t), more preferably
approximately 2 seconds following the time of maximum
h(t). For example, it has been found that a time interval of 2 to
40 4 seconds following the time of maximum value of h(t) is
suitable. Longer time intervals may also be used. Typically
the appropriate time interval is predetermined, but in certain
embodiments of the invention it may be selected as the mea-
surements are being made.
45 The following exponential equation is the basis of the
resulting least squares problem where A and TD are param-
eters to be estimated through the least squares minimization
of w(t).
h(t)=Ae-t/tom+w(t),
50
By first log transforming h(t) over the interval of interest
(which is always greater than zero), the optimal estimate of
the parameters in the least squares sense may be estimated
through an analytic linear least squares solution [4]. CO may
55 then be computed to within a constant scale factor equal to
I/AC through the ratio of the ABP signal to TD as discussed
above. Note that TPR of the systemic or pulmonary arterial
tree (depending on the signal measurement site) is trivially
given, to within a constant scale factor equal to AC, by TD.
60 In the embodiment of the invention described above pro-
portional CO is determined by dividingABP by TD. In another
embodiment of the invention, rather than employingABP, the
method uses the arterial-systemic filling pressure difference
(ASFPD). The ASFPD is determined by subtracting systemic
65 venous pressure from arterial blood pressure [54]. The sys-
temic filling pressure can either be measured, or more com-
monly estimated. All the analyses described above can then
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be performed on the ASFPD rather than on the ABP signal,
including estimation of the cardiac output. In this embodi-
ment the ASFPD is divided by the time constant to obtain a
signal proportional to cardiac output.
This embodiment of the invention offers a number of
potential advantages. In the absence of cardiac contractions
the arterial blood pressure would decay over time to the
systemic filling pressure, thus it is not fully accurate to
describe the decay of the ABP impulse reponse function at
long times as an exponential that decays to zero. However,
since in the absence of cardiac contractions the ASFPD does
decay to zero, a description in terms of an exponential decay
at long times is more appropriate for the impulse response
function of the ASFPD. Furthermore, since the time constant
of the impulse response function is estimated at long times
when the impulse response function has already decayed
substantially, even if the systemic filling pressure is small,
there may be a significant difference in the decay constant
estimated from the impulse response functions of the ABP
compared to the ASFPD with the analysis of the ASFPD
providing a more accurate result.
FIG. 4 depicts a block diagram illustrating a preferred
embodiment of the present invention. An analog ABP signal
is fed into an analog-to-digital converter as it is being mea-
sured. The ABP signal may be acquired using standard meth-
ods, such as those mentioned above. In certain embodiments
of the invention a surface electrocardiogram is also obtained
(ECG), e.g., via standard ECG leads. The digitized ABP
signal is stored in a buffer system. The most recent 60-90
second intervals of the digitized signal are transferred from
the buffer system to a processing unit which analyzes the
signal according to FIG. 3 in order to estimate ti me . The buffer
and processing unit may be implemented using, for example,
any standard microcomputer running appropriate software to
implement the mathematical operations described above. The
software components of the invention may be coded in any
suitable programming language and may be embodied in any
of a ragne of computer-readable media including, but not
limited to, floppy disks, hard disks, CDs, zip disks, DVD
disks, etc. Outputs such as proportional CO, CO, and TPR
may be displayed on a visual display such as a computer
screen and/or may be printed or transmitted to a remote loca-
tion. The ECG, and analysis thereof, may also be displayed.
In a preferred embodiment of the system the process is con-
tinuously repeated thereby providing the on-line monitoring
of CO and TPR (with a delay of 30-45 seconds). Finally, in
certain embodiments of the invention an alarm is triggered
upon excessive decreases in CO.
Alternatively, the AC proportionality constant may be
computed with a single absolute measure of CO (e.g., ther-
modilution) through the product of TD and the measured CO
divided by ABP, as discussed above. The proportionality con-
stant AC may then be utilized to obtain absolute measures of
CO and TPR. Note that physiologic changes in AC due to
disease or aging may also be monitored with multiple, simul-
taneous measurements of absolute CO and an ABP signal.
The present invention was evaluated in a pilot study in
which femoral ABP and aortic flow probe CO were simulta-
neously measured in an experimental rabbit preparation dur-
ing various interventions known to alter CO (e.g., pacing,
inferior vena cava balloon occlusion, and nitroglycerine).
FIG. 5 illustrates that the resulting relative changes in CO
with respect to baseline predicted by the present invention
correspond to those changes determined from the aortic flow
probe. In FIG. 5 the x-axis represents the percentage change
in CO as measured using the aortic flow probe, while the
y-axis represents the percentage change in CO as determined
using the present invention. The solid line (line of identity)
represents results that would be achieved by a technique that
precisely replicated the aortic flow probe measurements. The
dashed line represents the values measured using the present
5 invention and demonstrates a very close fit.)
The invention was further evaluated in six experiments in
swine, in which peripheral ABP signals and independent CO
via an aortic flow probe were simultaneously measured over
a wide physiologic range. Six Yorkshire swine (30-34 kg)
10 were studied under a protocol approved by the MIT Commit-
tee on Animal Care. The animals were given intramuscular
tiletamine-zolazepam, xylazine, and atropine prior to endot-
racheal intubation. The swine were then maintained in a deep
plane of anesthesia with inhaled isoflorane 0.5%-4%. Posi-
15 tive-pressure mechanical ventilation at a rate of 10-15
breaths/min and a tidal volume of 500 ml was employed.
Physiologic transducers were placed as follows. 7.5 French
sheath introducers (Arrow International, Reading, Pa.) were
placed in the bilateral femoral arteries. A micromanometer-
20 tipped catheter (SPC 350, Millar Instruments, Houston, Tex.)
was fed retrograde to the thoracic aorta from the femoral
artery for central ABP. The catheter was specifically posi-
tioned to achieve a diastolic decay that appeared as exponen-
tial as possible. The second introducer was attached to stiff
25 fluid-filled tubing (Arrow International) and an external pres-
sure transducer (TSDI04A, Biopac Systems, Santa Barbara,
Calif.) for femoral ABP. The chest was opened with a midline
sternotomy. An ultrasonic flow probe was placed around the
aortic root for gold standard CO (T206 with A-series probes,
30 Transonic Systems, Ithaca, N.Y.). Finally, a 23- or 25-gauge
angiocatheter was placed as distal as possible to the brachial
artery and attached to an external pressure transducer via
short, rigid tubing for "radial' ABP. Each transducer output
was interfaced to a microcomputer via an A/D conversion
35 system (MP150WSW, Biopac Systems). The data were
recorded at a sampling rate of 250 Hz and 16-bit resolution.
In each animal, a subset of the following interventions was
performed over the course of 75 to 150 minutes to vary CO
and other hemodynamic parameters: infusions of volume,
40 phenylephrine, dobutamine, isuprel, esmolol, nitroglycerine,
and progressive hemorrhage. Several infusion rates were
implemented followed by brief recovery periods.
The technique was applied off-line to six-minute intervals
(overlapping by three minutes) of the digitized "radial' and
45 femoral ABP signals to estimate ti and proportional CO
trends. The corresponding gold standard CO trends were
established by averaging the aortic flow probe measurements
over the identical time intervals. Gold standard T trends were
similarly sought by applying the technique of Bourgeois et al
so [4] to the central ABP signals. As a metric for comparison
between an estimated trend (X(i)) and the corresponding gold
standard trend (X ji)), the root-mean-square-normalized-er-
ror (RMSNE) in percent was computed as follows:
55
	
N	 z
	
RMSNE = N	 ri) tXow .100%,
60
where N represents the number of analyzed six-minute inter-
vals and the argument i denotes the i th analyzed six-minute
interval. In order to use this metric to compare an estimated
65 proportional CO trend with the corresponding absolute gold
standard CO trend, the former trend was first scaled to have
the same mean value as the latter trend for each animal. The
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correlation coefficient (p) between the estimated and gold
standard trends was also calculated as a scale-invariant metric
for comparison.
FIG. 6 illustrates example excerpts of the digitized central,
"radial", and femoral ABP signals. The central ABP excerpt is
from the beginning of the recording period in which the aortic
catheter was positioned such that the diastolic decay appeared
as exponential as possible. Unfortunately, the diastolic decay
of the central ABP signal did not consistently appear as a
single exponential throughout the recording period in which
various interventions were employed. The "radial' and femo-
ral ABP excerpts are from the same time but later in the
recording period. Although the diastolic decay of the femoral
ABP excerpt appears smooth, it cannot be adequately repre-
sented by a single exponential function.
Table 1 summarizes the results for each animal, and FIGS.
7 and 8 are examples of the corresponding trends for animal
1 (worst result) and animal 5 (best result). (The femoral ABP
signal of animal 4 was not analyzed due to excessive damp-
ing.) The table and figures illustrate the wide physiologic
range imposed by the interventions and strong agreement
between the estimated and gold standard CO trends (in terms
of CO RMSNE and visually). This strong agreement was
confirmed by high overall r values (mean±SD) between the
gold standard CO trends and the CO trends estimated from the
"radial" (0.84±0.07) and femoral (0.86±0.05) ABP signals.
Additionally, Table 2 shows that the CO errors (difference
between calibrated, estimated CO trends and corresponding
gold standard CO trends) were largely uncorrelated with CO,
mean ABP (MAP), and heart rate (HR).
TABLE 1
14
The low overall TD
 
RMSNE in the table is buttressed by a high
overall p value (mean±SD) between the two TD trend esti-
mates (0.85±0.08). Thus, there is solid agreement between
the two TD trend estimates despite substantial differences in
5 short-time scale morphology between the "radial' and femo-
ral ABP signals (FIG. 6), and the overall CO measurement
error is only 14.6%. Preliminary studies show that the six-
minute intervals used here may be reduced to, for example,
to three-minute intervals without materially affecting the
results.
In certain other embodiments of the invention it may be
desirable to adjust the proportionality constant AC to vary
depending on the arterial blood pressure or heart rate, if it is
15 found that there is a systematic difference between depen-
dence of the estimated cardiac output and the absolute cardiac
output on heart rate or arterial blood pressure.
The foregoing description is to be understood as being
representative only and is not intended to be limiting. Alter-
20 native systems and techniques for implementing the methods
of the invention will be apparent to one of skill in the art and
are intended to be included within the accompanying claims.
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Summary of results. CO is cardiac output; MAP, mean arterial pressure;
HR, heart rate; RMSNE, root-mean-square-normalized-error;
and T„ longtime constant of arterial tree.
CO RANGE MAP RANGE HR RANGE CO RMSNE [%] TD RMSNE
ANIMAL [L/MLN]	 [MMHG]	 [BPM]	 femoral "radial"	 1%]
1 1.6-5.2 29-100 96-180 19.9 19.1 8.3
2 2.3-4.2 54-127 101-204 10.2 16.0 5.9
3 1.9-5.8 70-120 96-186 8.8 16.7 14.7
4 1.3-4.3 27-106 103-198 12.3
5 2.4-5.0 65-118 91-198 10.2 8.0 9.7
6 2.3-5.6 52-108 109-177 17.1 14.7 12.4
TOTAL 1.3-5.8 27-127 91-204 14.0 15.0 10.3
TABLE 2
Correlation coefficient (p) matrix. ABP is arterial
blood pressure. See Table 1 caption.
CO MAP	 HR
"RADIAL" ABP CO ERRORS	 0.11	 0.47	 -0.08
FEMORAL ABP CO ERRORS	 0.09	 0.32	 0.14
Since we were not able to obtain gold standard TD trends
from the central ABP signals, we compared the two TD trends
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We claim:	 35
1. An apparatus for determining cardiac output to within a
constant scale factor comprising a computer system that
includes:
(a)computer readable media having code comprising com-
puter-executable process steps; and 	 40
(b) a processor that executes the process steps to:
(i) accept an input representing a measurement of an
arterial blood pressure signal over a plurality of car-
diac cycles;
(ii) estimate a function that represents the response of 45
the arterial blood pressure to a single cardiac contrac-
tion;
(iii) fit the function of step (ii) to an exponential-like
function over a time period that begins a selected 
50
amount of time following the maximum value of the
function;
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(iv) estimate the time constant of the function of step (ii)
as the time constant of the exponential function of step
(iii); and
(v) determine cardiac output to within a constant scale
factor by dividing average arterial blood pressure by
the time constant obtained in step (iv).
2. The apparatus of claim 1, further comprising an analog-
to-digital converter.
3. The apparatus of claim 1, wherein the apparatus includes
• buffer system.
4. The apparatus of claim 1, wherein the apparatus includes
• display device.
5. The apparatus of claim 1 wherein arterial bloodpressure
is measured invasively or non-invasively at any site in the
systemic or pulmonary arterial tree.
6. The apparatus of claim 1 wherein arterial bloodpressure
is further defined as systemic arterial pressure.
7. The apparatus of claim 1 wherein arterial bloodpressure
is further defined as pulmonary blood pressure.
8. An apparatus for determining cardiac output to within a
scale factor comprising a computer system that includes:
(g) computer readable media having code comprising com-
puter-executable process steps; and
(h) a processor that executes the process steps to:
i. accept an input representing a measurement of an
arterial blood pressure signal over a plurality of car-
diac cycles;
ii. capture long time scale information by estimating an
impulse response which when convolved with cardiac
contractions fits the arterial blood pressure signal;
iii. obtain a time constant by fitting an exponential-like
function to the estimated impulse response over a time
period that begins a selected amount of time following
its maximum value;
iv. determine cardiac output to within a scale factor by
dividing a measure of the average arterial blood pressure
by the time constant.
9. The apparatus of claim 8 further comprising an analog-
to-digital converter.
10. The apparatus of claim 8 wherein the apparatus
includes a buffer system.
11. The apparatus of claim 8 wherein the apparatus
includes a display device.
12. The apparatus of claim 8 wherein arterial blood pres-
sure is measured invasively or non-invasively at any site in the
systemic or pulmonary arterial tree.
13. The apparatus of claim 8 wherein arterial blood pres-
sure is further defined as systemic arterial pressure.
14. The apparatus of claim 8 wherein arterial blood pres-
sure is further defined as pulmonary blood pressure.
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